MedTrace Logo

Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children

NCT01750463 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2014-12-03

No results posted yet for this study

Summary

This is a prospective study to determine the accuracy of the Masimo Pronto Non-Invasive Hemoglobin Monitor and associated Rainbow® probes in the detection of hemoglobin concentration in critically ill children.

Conditions

  • Hemoglobin Results

Interventions

OTHER

Masimo Pronto Rad 7 Non-Invasive hemoglobin monitor

Patients admitted to PICU requiring hemoglobin monitoring will have a total hemoglobin (SpHb) assessment from Masimo non-invasive monitor, prior to standard, required blood draw and laboratory analysis.

OTHER

Standard Laboratory Blood Draw and Hemoglobin Analysis

Patients admitted to PICU requiring hemoglobin monitoring will have a reading from Masimo non-invasive monitor, prior to standard, required blood draw and laboratory analysis.

Sponsors & Collaborators

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Michael Phillips, MD · University of North Carolina,Chapel Hill, NC

Eligibility

Min Age
30 Days
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01750463 on ClinicalTrials.gov